Is lecanemab the Alzheimer's drug that will finally make a difference?

By WBUR / NPR
| December 08, 2022

The drug, a monoclonal antibody called lecanemab, dominated last week's Clinical Trials on Alzheimer's Disease meeting in San Francisco.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...